Q2 FY2026 · ended Jun 30, 2026 · Revenue $70.49M, -12.7% YoY · Filed Aug 6, 2026
Health Catalyst, Inc. (HCAT) files with the SEC under industry code 7370, Services-Computer Programming, Data Processing, Etc. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $70.5 million and a net loss of $40.5 million. Free cash flow was -$70,000. As of Jun 30, 2026 it held $103.4 million in cash and investments and $170.0 million in total debt.
Company profile
- Industry
- Services-Computer Programming, Data Processing, Etc. (SIC 7370)
- Listed as
- HCAT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South Jordan, UT
- SEC filer status
- Accelerated filer
- SEC CIK
- 1636422
- Former names
- HQC Holdings, Inc. (until Feb 19, 2016)
Other Services-Computer Programming, Data Processing, Etc. companies
- Alphabet Inc. GOOGL
- Meta Platforms, Inc. META
- AppLovin Corp APP
- Nebius Group N.V. NBIS
- Bending Spoons S.p.A. BSP
- Zoom Communications, Inc. ZM
- Baidu, Inc. BIDU
- Flutter Entertainment plc FLUT
All 94 Services-Computer Programming, Data Processing, Etc. companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $70.5M | $70.8M | $74.7M | $76.3M | $80.7M |
| Operating income | -$36.5M | -$106.5M | -$86.1M | -$17.5M | -$37.1M |
| Net income | -$40.5M | -$111.0M | -$91.0M | -$22.2M | -$41.0M |
| Diluted EPS | -$0.55 | -$1.53 | -$1.28 | -$0.32 | -$0.59 |
| Operating cash flow | $275,000 | $18.5M | $9.9M | -$464,000 | -$9.0M |
| Free cash flow | -$70,000 | $18.2M | $9.6M | -$719,000 | -$9.2M |
| Total assets | $358.6M | $412.2M | $502.6M | $587.1M | $616.2M |
| Total liabilities | $257.8M | $274.1M | $256.9M | $255.2M | $268.6M |
| Stockholders' equity | $100.8M | $138.1M | $245.8M | $331.9M | $347.5M |
| Cash and investments | $103.4M | $108.8M | $95.7M | $91.5M | $97.3M |
| Total debt | $170.0M | $170.6M | $171.2M | $172.1M | $172.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 14, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2026 | Sep 4, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Agreement ended, Acquisition or sale of assets, Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Jul 31, 2026 |
All 935 Health Catalyst, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.